Blood-brain barrier protects the central nervous system from conventional therapeutics. This feed focuses on the development and use of nanomedicine for neurological diseases.

December 7, 2021

Stimuli-responsive nanomaterials for cancer treatment: boundaries, opportunities and applications.

Chemical Communications : Chem Comm
Nuria Lafuente-GómezÁlvaro Somoza
December 7, 2021

Nanoscale self-assembly: concepts, applications and challenges.

Eberechukwu Victoria AmadiChris Papadopoulos
December 7, 2021

Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.

The AAPS Journal
Purva KhareDevika S Manickam
December 7, 2021

Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.

Journal of Nanobiotechnology
Jun-Yong WuDa-Xiong Xiang
December 7, 2021

A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease.

CNS & Neurological Disorders Drug Targets
Ozlem Bahadır AcıkaraHamid Reza Khayat Kashani
December 7, 2021

Biomacromolecule-Functionalized Nanoparticle-Based Conjugates for Potentiation of Anticancer Therapy.

Current Cancer Drug Targets
Priyank Shah, Pravin Shende
December 7, 2021

Precision biomaterials in cancer theranostics and modelling.

David CaballeroSubhas C Kundu
December 7, 2021

Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy.

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Bowen JiangZhigang Xie
December 6, 2021

Evaluating the impact of systematic hydrophobic modification of model drugs on the control, stability and loading of lipid-based nanoparticles.

Journal of Materials Chemistry. B, Materials for Biology and Medicine
Cameron HogarthTom O McDonald
December 6, 2021

Toward enzyme-responsive polymersome drug delivery.

Bipin Chakravarthy ParuchuriJessica Larsen
December 6, 2021
Comment / Editorial

Editorial: Stimuli-Responsive Nanoparticles for Anti-cancer Therapy.

Frontiers in Bioengineering and Biotechnology
Saji UthamanMitsuhiro Ebara
December 6, 2021

Research Progress on Cell Membrane-Coated Biomimetic Delivery Systems.

Frontiers in Bioengineering and Biotechnology
Mengyu GuoWeidong Li
December 6, 2021

Emerging 2D Nanomaterials for Multimodel Theranostics of Cancer.

Frontiers in Bioengineering and Biotechnology
Wei ZhuPeng Luo
December 6, 2021

Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics.

Frontiers in Chemistry
Xinyu ZhangQingwei Meng

Sign up to follow this feed and discover related papers.

Related Feeds


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2021 Meta ULC. All rights reserved